Skip to main content

Table 1 Univariate analysis factors associated with PFS or OS

From: Classification of gallbladder cancer by assessment of CD8+ TIL and PD-L1 expression

Ā 

OS

PFS

HR (95% CI)

P-value

HR (95% CI)

P-value

Clinical parameters

Age, (ā‰¤ 65 vā€‰>ā€‰Ā 65)

1.50 (0.84ā€“2.67)

Pā€‰=ā€‰0.170

1.39 (0.81ā€“2.39)

Pā€‰=ā€‰0.230

Sex, (Male v Female)

1.18 (0.68ā€“2.06)

Pā€‰=ā€‰0.559

1.061 (0.66ā€“1.81)

Pā€‰=ā€‰0.829

TNM stage, (Iā€‰+ā€‰II vs. IIIā€‰+ā€‰IV)

2.76 (1.45ā€“5.24)

Pā€‰=ā€‰0.002

2.10 (1.18ā€“3.73)

Pā€‰=ā€‰0.012

Risk factors

ā€ƒGall stone (no v yes)

1.58 (0.89ā€“2.81)

Pā€‰=ā€‰0.117

1.47 (0.85ā€“2.54)

Pā€‰=ā€‰0.166

ā€ƒDiabetes (no v yes)

1.27 (0.66ā€“2.45)

Pā€‰=ā€‰0.467

1.15 (0.64ā€“2.05)

Pā€‰=ā€‰0.640

ā€ƒHypertension (no v yes)

1.40 (0.77ā€“2.52)

Pā€‰=ā€‰0.270

1.50 (0.86ā€“2.63)

Pā€‰=ā€‰0.156

ā€ƒCholecystitis (no v yes)

1.34 (0.74ā€“2.41)

Pā€‰=ā€‰0.335

1.34 (0.77ā€“2.35)

Pā€‰=ā€‰0.304

Jaundice (no v yes)

2.82 (1.49ā€“5.33)

Pā€‰=ā€‰0.001

2.58 (1.35ā€“4.92)

Pā€‰=ā€‰0.004

Completed resection (no v yes)

0.38 (0.21ā€“0.68)

Pā€‰=ā€‰0.001

0.40 (0.22ā€“0.72)

Pā€‰=ā€‰0.002

CEA (>ā€‰ 5Ā Ī¼g/L)

1.97 (1.08ā€“3.60)

Pā€‰=ā€‰0.028

1.61 (0.90ā€“2.89)

Pā€‰=ā€‰0.110

CA19ā€“9 (>ā€‰ 34Ā U/mL)

2.77 (1.52ā€“5.06)

Pā€‰=ā€‰0.001

2.28 (1.28ā€“4.04)

Pā€‰=ā€‰0.005

Liver dysfunction

ā€ƒALT (>ā€‰ 40Ā U/L)

2.13 (1.15ā€“3.95)

Pā€‰=ā€‰0.016

2.04 (1.10ā€“3.79)

Pā€‰=ā€‰0.023

ā€ƒAST (>ā€‰ 35Ā U/L)

1.63 (0.91ā€“2.91)

Pā€‰=ā€‰0.099

1.34 (0.79ā€“2.42)

Pā€‰=ā€‰0.264

ā€ƒTBil (>ā€‰ 22.2Ā Ī¼mol/L)

1.625 (0.91ā€“2,90)

Pā€‰=ā€‰0.101

1.38 (0.79ā€“2.44)

Pā€‰=ā€‰0.261

ā€ƒDBil (>ā€‰ 6.8Ā Ī¼mol/L)

2.71 (1.50ā€“4.91)

Pā€‰=ā€‰0.001

2.45 (1.35ā€“4.47)

Pā€‰=ā€‰0.003

ā€ƒGGT (>ā€‰ 45Ā U/L)

2.34 (1.31ā€“4.17)

Pā€‰=ā€‰0.004

2.055 (1.17ā€“3.61)

Pā€‰=ā€‰0.013

ā€ƒALP (>ā€‰ 135Ā U/L)

1.99 (1.12ā€“3.56)

Pā€‰=ā€‰0.020

1.75 (0.99ā€“3.08)

Pā€‰=ā€‰0.055

Pathological features

Differentiation (moderate vs. poor)

1.95 (1.10ā€“3.46)

Pā€‰=ā€‰0.023

1.57 (0.92ā€“2.68)

Pā€‰=ā€‰0.100

Mean tumor size (ā‰¤ 3.0 vā€‰>ā€‰3.0Ā cm)

1.07 (0.61ā€“1.88)

Pā€‰=ā€‰0.816

1.02 (0.60ā€“1.72)

Pā€‰=ā€‰0.955

Immunohistochemistry

ā€ƒCD133+ in TCs

1.09 (0.62ā€“1.91)

Pā€‰=ā€‰0.776

0.99 (0.58ā€“1.71)

Pā€‰=ā€‰0.994

ā€ƒCD8+ TILs (CD8low vs. CD8high)

0.49 (0.28ā€“0.86)

Pā€‰=ā€‰0.014

0.54 (0.31ā€“0.93)

Pā€‰=ā€‰0.026

ā€ƒPD-1+ in TILs

1.14 (0.66ā€“1.98)

Pā€‰=ā€‰0.636

1.26 (0.74ā€“2.13)

Pā€‰=ā€‰0.398

ā€ƒPD-L1+ in TCs

1.92 (0.95ā€“3.88)

Pā€‰=ā€‰0.067

1.87 (0.95ā€“3.68)

Pā€‰=ā€‰0.071

ā€ƒPD-L1āˆ’ vs. PD-L1+

1.86 (1.04ā€“3.33)

Pā€‰=ā€‰0.038

1.60 (0.93ā€“2.75)

Pā€‰=ā€‰0.088

ā€ƒPD-L2- vs. PD-L2+

1.52 (0.82ā€“2.80)

Pā€‰=ā€‰0.185

1.40 (0.80ā€“2.46)

Pā€‰=ā€‰0.242

Classification based on PD-L1 expression and CD8+ TILs

ā€ƒOverall

NA; Pā€‰=ā€‰0.003

NA; Pā€‰=ā€‰0.018

ā€ƒI vs. II

3.14 (1.11ā€“8.85)

Pā€‰=ā€‰0.031

2.40 (1.03ā€“5.59)

Pā€‰=ā€‰0.042

ā€ƒI vs. III

3.36 (1.21ā€“9.30)

Pā€‰=ā€‰0.020

2.75 (1.16ā€“6.51)

Pā€‰=ā€‰0.021

ā€ƒI vs. IV

7.38 (2.49ā€“21.89)

<ā€‰0.001

4.81 (1.81ā€“12.78)

Pā€‰=ā€‰0.002

  1. NOTE: Univariate analysis, Cox proportional hazards regression model